News - Page 190 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders

atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders

Post published:April 7, 2021
Post category:Press Release

Read more about the article Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology

Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology

Post published:April 7, 2021
Post category:Press Release

Read more about the article Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

Post published:April 7, 2021
Post category:Press Release

Read more about the article Lobe Sciences Appoints Ilan Hayman to Advisory Board

Lobe Sciences Appoints Ilan Hayman to Advisory Board

Post published:April 6, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test

Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test

Post published:April 6, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Listing on OTCQB and DTC Eligibility

Tryp Therapeutics Announces Listing on OTCQB and DTC Eligibility

Post published:April 5, 2021
Post category:Press Release

Read more about the article MindMed Announces the Publication of New Data on Personalized MDMA Dosing

MindMed Announces the Publication of New Data on Personalized MDMA Dosing

Post published:April 5, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: UCSF Launches Psychedelics Division; New Additions to the Psychedelics ETF; Massachusetts City Decriminalizes Psychedelics

Psychedelic Bulletin: UCSF Launches Psychedelics Division; New Additions to the Psychedelics ETF; Massachusetts City Decriminalizes Psychedelics

Post published:April 2, 2021
Post category:Psychedelic Bulletin

Read more about the article Tryp Therapeutics Announces Amendment to Option Plan and Option Grant

Tryp Therapeutics Announces Amendment to Option Plan and Option Grant

Post published:April 2, 2021
Post category:Press Release

Read more about the article COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors

COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors

Post published:April 1, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.